Clinical Trial Update: Burosumab in Children and Adolescents With X-linked Hypophosphatemia [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for burosumab in children and adolescents with X-linked hypophosphatemia (XLH).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• X-linked Hypophosphatemia

Drugs mentioned

• Burosumab (burosumab)

Snippet

Sponsor: Bicetre Hospital | Conditions: Rare Diseases, X-linked Hypophosphatemia | Phase 4 | Status: UNKNOWN